Enhanced liver fibrosis test for the non-invasive diagnosis of fibrosis in patients with NAFLD: A systematic review and meta-analysis-Reference-Cited by-同舟云学术

Enhanced liver fibrosis test for the non-invasive diagnosis of fibrosis in patients with NAFLD: A systematic review and meta-analysis

Published:2020-08 Issue:2 Volume:73 Page:252-262
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Vali Yasaman,Lee Jenny,Boursier Jérôme,Spijker René,Löffler Jürgen,Verheij Joanne,Brosnan M. Julia,Böcskei Zsolt,Anstee Quentin M.,Bossuyt Patrick M.,Zafarmand Mohammad Hadi,Pavlides Michael,Levick Christina,Duffin Kevin,Hyde Craig,Bauer Tim,Bedossa Pierre,Leeming Diana,Daly Ann,Hanf Remy,Ortiz Pablo,Oresic Matej,Schuppan Detlef,Hanauer Guido,Chen Yu,Shumbayawonda Elizabeth,Bjerring Peter Nissen,Zwinderman Koos

Funder

Innovative Medicines Initiative

Publisher

Elsevier BV

Subject

Hepatology

Reference61 articles.

1. Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases;Adams;Gut,2017

2. Efficacy of synbiotic supplementation in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis of clinical trials: synbiotic supplementation and NAFLD;Hadi;Crit Rev Food Sci Nutr,2019

3. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes;Younossi;Hepatology,2016

4. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008;Younossi;Clin Gastroenterol Hepatol,2011

5. Portal inflammation is independently associated with fibrosis and metabolic syndrome in pediatric nonalcoholic fatty liver disease;Mann;Hepatology,2016

Cited by 192 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Population screening for cirrhosis;Hepatology Communications;2024-08-26

2. A roadmap for clinical trials in MASH-related compensated cirrhosis;Nature Reviews Gastroenterology & Hepatology;2024-07-17

3. A Precision Medicine Guided Approach to the Utilization of Biomarkers in MASLD;Seminars in Liver Disease;2024-07-11

4. Noninvasive Tests to Assess Fibrosis and Disease Severity in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic-Dysfunction-Associated Steatohepatitis;Seminars in Liver Disease;2024-07-09

5. Aramchol improves hepatic fibrosis in metabolic dysfunction–associated steatohepatitis: Results of multimodality assessment using both conventional and digital pathology;Hepatology;2024-06-25